Perceptive Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Perceptive Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,700	Closed	-$982K	–	126
2018 Q3	$982K	Hold	5,700	–	–	0.03%	91
2018 Q2	$876K	Hold	5,700	–	–	0.02%	97
2018 Q1	$958K	Hold	5,700	–	–	0.03%	109
2017 Q4	$557K	Hold	5,700	–	–	0.02%	118
2017 Q3	$590K	Buy	+5,700	New	+$425K	0.02%	116
2016 Q4	–	Sell	-132,057	Closed	-$4.07M	–	217
2016 Q3	$4.07M	Buy	+132,057	New	+$3.83M	0.26%	76

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Perceptive Advisors's ONC Position: Q4 2018 in Review

Perceptive Advisors sold out of BeOne Medicines Ltd (ONC) in Q4 2018, closing a stake of 5,700 shares — an estimated $982K sold.

Perceptive Advisors first reported a position in ONC in Q3 2016 and held it in 6 quarters. The position peaked at $4.07M in Q3 2016. 192 funds tracked by Wall St. Rank hold ONC as of Q4 2018.

Perceptive Advisors reported no remaining BeOne Medicines Ltd position as of Q4 2018 after selling out during the quarter.
Perceptive Advisors sold 5,700 BeOne Medicines Ltd shares in Q4 2018, an estimated $982K.
Perceptive Advisors first reported a position in BeOne Medicines Ltd in Q3 2016 and held it in 6 quarters.
Perceptive Advisors's BeOne Medicines Ltd position peaked at $4.07M in Q3 2016.
192 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2018.

Based on Perceptive Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.